Advantech Capital is a Hong Kong-based venture capital firm founded in January 2016 by Jianming Yu that focuses on innovation-driven. See contact routes.
Advantech Capital is a Hong Kong-based venture capital firm founded in January 2016 by Jianming Yu that focuses on innovation-driven growth capital in China. The firm targets early and late-stage ventures, primarily investing in the healthcare and technology, media, and telecommunications (TMT) sectors within China. It seeks to make minority investments through growth equity and later-stage venture capital, with portfolio locations spanning China and the United States. Notable portfolio companies include Kaiyi Technology, Alphamab Oncology, Mojo Vision, and InventisBio, while significant exits comprise Ideanomics, ZAI Lab, and Qutoutiao. As of March 2020, the firm had completed 25 investments, with its most recent recorded deal being a CN¥100M raise for Kaiyi Technology in June 2019. Advantech Capital operates a single fund, Advantech Capital Fund I, which raised $350M upon its announcement in August 2015, though other sources cite a total fund size of $560M. The firm distinguishes itself by backing innovation-driven opportunities in deep tech and life sciences, with three unicorns in its portfolio of 25 companies.
StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Central.
Investors like Advantech Capital · Full investor directory · Investor access · Company funding database